PAUL EHRLICH INST BUNDESAMT FU has a total of 23 patent applications. Its first patent ever was published in 1987. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are HEALTHBANKS BIOTECH CO LTD, STICHTING INST DIERHOUDERIJ and PASTORAL GREENHOUSE GAS RES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | China | 2 | |
#4 | Canada | 1 | |
#5 | Germany | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Preservation of human bodies | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Montag-Lessing Thomas | 9 |
#2 | Loeschner Bettina | 9 |
#3 | Spreitzer Ingo | 9 |
#4 | Suezer Yasemin | 6 |
#5 | Sutter Gerd | 6 |
#6 | Rimmelzwaan G F | 4 |
#7 | Osterhaus A D M E | 4 |
#8 | Reese Gerald | 3 |
#9 | Vieths Stefan | 3 |
#10 | Loewer Johannes | 3 |
Publication | Filing date | Title |
---|---|---|
EP2161344A1 | Method for the quantitative detection of an organic substance in a sample | |
EP2068149A1 | Method for determining the toxicity of a toxin or a toxoid | |
CN101636177A | The vaccine that is used for bird flu based on recombinant modified vaccinia virus ankara (MVA) | |
EP2020240A1 | Methods and substances for the treatment of Alzheimer's | |
EP1908346A1 | Method for the production of frozen blood or frozen blood cells for biological assays | |
WO2007054159A1 | Apparatus for obtaining cell suspensions with subsequent admixture of additives and corresponding methods | |
EP1837658A1 | Cytokine-based pyrogen test | |
EP1835031A1 | Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans | |
EP1787512A1 | Method for the cryopreservation of human blood | |
DE3712334A1 | Process for the cultivation of HIV-2 viruses, cell cultures suitable therefor, and diagnostic agents for the detection of HIV-2 viruses and process for their production |